5-hydroxytryptamine subtype 6 receptor modulators: a patent survey

By Ivachtchenko Alexandre V   Ivanenkov Yan A   Tkachenko Sergey E  

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 9, 2010-09 ,pp. : 1171-1196

Informa Healthcare

Access to resources Recommend Favorite

5-Hydroxytryptamine (5-HT) Receptor Ligands

By  

Current Pharmaceutical Design, Vol. 13, Iss. 25, 2007-09 ,pp. : 2621-2637

Bentham Science Publishers

Access to resources Recommend Favorite

5-Hydroxytryptamine interaction with the nicotinic acetylcholine receptor

By Blanton M.P.   McCardy E.A.   Fryer J.D.   Liu M.   Lukas R.J.  

European Journal of Pharmacology, Vol. 389, Iss. 2, 2000-02 ,pp. : 155-163

Elsevier

Access to resources Recommend Favorite

Relationship Between the 5-HT₃ Receptor Pharmacophore and the Conformations of 5-Hydroxytryptamine

By Daveu C.   Bureau R.   Rault S.  

Pharmacy and Pharmacology Communications, Vol. 6, Iss. 2, 2000-02 ,pp. : 73-76

Pharmaceutical Press

Access to resources Recommend Favorite

LY367265, an inhibitor of the 5-hydroxytryptamine transporter and 5-hydroxytryptamine 2A receptor antagonist: a comparison with the antidepressant, nefazodone

By Pullar I.A.   Carney S.L.   Colvin E.M.   Lucaites V.L.   Nelson D.L.   Wedley S.  

European Journal of Pharmacology, Vol. 407, Iss. 1, 2000-10 ,pp. : 39-46

Elsevier

Access to resources Recommend Favorite